Associated Medical Professionals of New York, PLLC

Syracuse, New York 13210

0 studies enrolling now · 9 studies all time

What they study most

Advanced Prostate Cancer, Bladder Cancer, Cancer of the Prostate, Castration-resistant Prostate Cancer, Hormone Refractory Prostate Cancer, Hormone Sensitive Prostate Cancer, Metastatic Prostate Cancer, Non-muscle Invasive Bladder Cancer, Overactive Bladder, Prostate Cancer, Prostate Cancer Metastatic, Prostatic Neoplasms

Studies at this site

• Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) — Running, not enrolling
• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer — Running, not enrolling
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed
• Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer — Completed
• A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer — Completed
• Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) — Stopped early
• OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder — Completed
• DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma — Stopped early